New center will use cutting-edge AI to accelerate the creation of life-saving medicines AI Small Molecule Drug Discovery ...

The Icahn School of Medicine at Mount Sinai has launched the AI Small Molecule Drug Discovery Center, a bold endeavor that harnesses artificial intelligence (AI) to revolutionize drug development.

Experimental drug NU-9—a small molecule compound approved by the U.S. Food and Drug Administration (FDA) for clinical trials ...

The Inflation Reduction Act was intended to lower prescription drug costs, but an unintended consequence is threatening the ...

When the mechanisms that replicate or repair mitochondrial DNA (mtDNA) fail, it can cause a wide range of syndromes for which ...

New York, NY, April 02, 2025 (GLOBE NEWSWIRE) -- The Icahn School of Medicine at Mount Sinai has launched the AI Small Molecule Drug Discovery Center, a bold endeavor that harnesses artificial ...

Lariocidin was efficient against strains of E. coli, including drug-resistant ones, according to the new study.

AlphaFold 3, the improved version of the model used by Isomorphic Labs’ drug design engine, debuted last May. It can predict ...

Researchers have discovered a new antibiotic molecule that targets a broad range of disease-causing bacteria — even strains resistant to commercial drugs — and is not toxic to human cells 1.

In a small Phase II trial, people with cocaine use disorder who took mavoglurant used the drug less often over a three month ...

When Medicare Part D was proposed in 2005, Democrats wanted to cap premiums at $41 per month because they thought that ...